• Your search
    starts here.

    Whether you're looking for answers or a second opinion, put one of the world's leading cancer care centers to work for you.


    Search adult cancer typesSearch pediatric cancer types  

    Make an appointment
    with our care specialists.

    Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

    Adult 877-442-3324

    Pediatric 888-733-4662

    Make an Appointment Online  
  • flex image

    Innovation

    Ground-breaking research
    starts on our grounds.

    For 70 years, we’ve led the world by making life-changing breakthroughs in cancer research and patient care. Each year, patients cross the globe to receive the most advanced care available, including over 700 innovative clinical trials. Our sole mission is to defeat cancer, especially yours.

    Research at dana-farber
    Find a Clinical Trial  

Newsroom

U.S. News and World Report Best Children's Hospital Cancer logo 2017-2018

Dana-Farber/Boston Children's again named a top national pediatric cancer program

June 27, 2017

U.S. News & World Report has ranked Dana-Farber/Boston Children's Cancer and Blood Disorders Center the nation's #2 pediatric cancer program in its new 2017-18 Best Children's Hospitals report.

 

Blog

supportive hands joined together

Cancer Survivors Offer Tips to New Patients Starting Treatment

Gaining the wisdom of another’s experience can be invaluable when facing something new — including cancer. Through the SoulMates program, newly diagnosed breast cancer patients can be paired with trained volunteers who have already been through surgery, chemotherapy, radiation, or other kinds of treatment.

 

Research

Precision Cancer Medicine - Nikhil Wagle, MD

Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.